A Phase II study to establish the efficacy and toxicity of sodium valproate in patients with cancer-related neuropathic pain

Journal of Pain and Symptom Management

Volumn 21, Issue 3, 2001, Pages 204-209

  Hardy, Janet R ^a   Rees, Elizabeth A J ^a   Gwilliam, Bridget ^a   Ling, Julie ^b   Broadley, Karen ^a   A'Hern, Roger ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ST LUKE S HOSPITAL   (Ireland)

Author keywords

Anti convulsant; Cancer; Neuropathic pain; Sodium valproate

Indexed keywords

VALPROIC ACID;

ADULT; AGED; ANALGESIA; APPETITE DISORDER; ARTICLE; BODY EQUILIBRIUM; CANCER PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; DROWSINESS; DRUG EFFICACY; DRUG TOXICITY; FEMALE; HUMAN; INDIGESTION; MALE; NAUSEA; NEUROPATHY; PHASE 2 CLINICAL TRIAL;

ADULT; AGED; ANTICONVULSANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NERVOUS SYSTEM DISEASES; PAIN; PALLIATIVE CARE; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0035119485     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(00)00266-9     Document Type: Article

References (10)

1. A systematic review of antidepressants in neuropathic pain
2. Psychotropic adjuvant analgesics for cancer pain
3. Anticonvulsant drugs for management of pain; a systematic review
4. Phenytoin as a coanalgesic in cancer pain
5. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases
6. Development and preliminary validation of a pain measure specific to neuropathic pain; The neuropathic pain scale
7. Cancer pain management according to WHO analgesic guidelines
8. Central post-stroke pain-a controlled trial of amitriptyline and carbamazepine
9. Placebo-controlled trials in palliative care; the argument for